Chinese General Practice ›› 2023, Vol. 26 ›› Issue (14): 1709-1715.DOI: 10.12114/j.issn.1007-9572.2022.0750
Special Issue: 心血管最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2022-08-12
Revised:
2022-11-19
Published:
2023-05-15
Online:
2022-12-02
Contact:
ZHONG Qiuan
通讯作者:
钟秋安
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0750
组别 | 例数 | 性别(男/女) | 年龄(岁) | 民族〔n(%)〕 | 受教育程度〔n(%)〕 | SBP(mm Hg) | DBP(mm Hg) | 吸烟〔n(%)〕 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
汉族 | 其他 | 初中及以下 | 高中及以上 | 从不吸烟 | 曾经吸烟 | 当前吸烟 | ||||||
CIMT正常组 | 693 | 202/491 | 56.0±10.2 | 451(65.1) | 242(34.9) | 616(88.9) | 77(11.1) | 137±20 | 79±13 | 547(78.9) | 63(9.1) | 83(12.0) |
CIMT增厚组 | 45 | 22/23 | 63.5±7.6 | 20(44.4) | 25(55.6) | 41(91.1) | 4(8.9) | 159±24 | 83±15 | 27(60.0) | 7(15.6) | 11(24.4) |
检验统计量值 | 7.789a | 4.847 | 7.793a | 0.213a | 7.231 | 2.147 | 8.965a | |||||
P值 | 0.005 | <0.001 | 0.005 | 0.644 | <0.001 | 0.032 | 0.011 | |||||
组别 | 饮酒〔n(%)〕 | 颈总动脉内径(mm) | BMI(kg/m2) | LDL-C(mmol/L) | HDL-C(mmol/L) | TG〔M(P25,P75),mmol/L〕 | TC(xmmol/L) | ACR〔M(P25,P75),mg/g〕 | eGFR〔ml·min-1·(1.73 m2)-1〕 | |||
从不饮酒 | 曾经饮酒 | 当前饮酒 | ||||||||||
CIMT正常组 | 349(50.4) | 95(13.7) | 249(35.9) | 6.5±0.8 | 23.6±3.2 | 3.0±0.9 | 1.6±0.4 | 1.6(1.1,2.2) | 5.4±1.0 | 7.6(3.9,15.1) | 88.8±16.3 | |
CIMT增厚组 | 20(44.4) | 4(8.9) | 21(46.7) | 7.4±0.8 | 22.8±3.3 | 3.0±0.8 | 1.6±0.5 | 1.6(1.0,2.1) | 5.8±1.0 | 13.8(9.0,39.3) | 85.4±12.9 | |
检验统计量值 | 2.358a | 7.152 | 1.635 | 0.196 | 0.403 | 0.402b | 3.095 | 5.157b | 1.376 | |||
P值 | 0.307 | <0.001 | 0.102 | 0.844 | 0.686 | 0.687 | 0.002 | <0.001 | 0.169 | |||
组别 | LPA〔M(P25,P75),mg/L〕 | ICAM-1〔M(P25,P75),μg/L〕 | VCAM-1〔M(P25,P75),μg/L〕 | ApoA/ApoB | CRP〔M(P25,P75),mg/L〕 | ALB〔M(P25,P75),mg/L〕 | GLU(mmol/L) | 糖尿病〔n(%)〕 | ALT〔M(P25,P75),U/L〕 | AST〔M(P25,P75),U/L〕 | PHYMET〔M(P25,P75),MET-min/w〕 | |
CIMT正常组 | 135.0(64.8,282.7) | 78.1(52.8,127.0) | 225.2(170.2,299.7) | 1.7±0.6 | 0.9(0.4,1.9) | 9.1(4.7,19.3) | 5.8±1.5 | 61(8.8) | 11.8(8.9,17.0) | 24.0(20.9,29.0) | 5 593(3 564,8 319) | |
CIMT增厚组 | 229.0(117.0,284.0) | 78.1(50.4,150.5) | 298.0(216.0,352.3) | 1.5±0.7 | 1.5(0.9,2.6) | 16.1(10.5,46.0) | 6.1±1.7 | 6(13.3) | 12.0(9.8,18.0) | 26.0(22.9,33.1) | 7 479(3 885,13 146) | |
检验统计量值 | 2.461b | 0.200b | 3.341b | 1.704 | 3.213b | 4.014b | 1.183 | 1.051a | 0.807b | 1.676b | 2.451b | |
P值 | 0.013 | 0.841 | <0.001 | 0.044 | <0.001 | <0.001 | 0.237 | 0.305 | 0.420 | 0.094 | 0.014 |
Table 1 Comparison of general data and cervical color ultrasound results between the two groups
组别 | 例数 | 性别(男/女) | 年龄(岁) | 民族〔n(%)〕 | 受教育程度〔n(%)〕 | SBP(mm Hg) | DBP(mm Hg) | 吸烟〔n(%)〕 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
汉族 | 其他 | 初中及以下 | 高中及以上 | 从不吸烟 | 曾经吸烟 | 当前吸烟 | ||||||
CIMT正常组 | 693 | 202/491 | 56.0±10.2 | 451(65.1) | 242(34.9) | 616(88.9) | 77(11.1) | 137±20 | 79±13 | 547(78.9) | 63(9.1) | 83(12.0) |
CIMT增厚组 | 45 | 22/23 | 63.5±7.6 | 20(44.4) | 25(55.6) | 41(91.1) | 4(8.9) | 159±24 | 83±15 | 27(60.0) | 7(15.6) | 11(24.4) |
检验统计量值 | 7.789a | 4.847 | 7.793a | 0.213a | 7.231 | 2.147 | 8.965a | |||||
P值 | 0.005 | <0.001 | 0.005 | 0.644 | <0.001 | 0.032 | 0.011 | |||||
组别 | 饮酒〔n(%)〕 | 颈总动脉内径(mm) | BMI(kg/m2) | LDL-C(mmol/L) | HDL-C(mmol/L) | TG〔M(P25,P75),mmol/L〕 | TC(xmmol/L) | ACR〔M(P25,P75),mg/g〕 | eGFR〔ml·min-1·(1.73 m2)-1〕 | |||
从不饮酒 | 曾经饮酒 | 当前饮酒 | ||||||||||
CIMT正常组 | 349(50.4) | 95(13.7) | 249(35.9) | 6.5±0.8 | 23.6±3.2 | 3.0±0.9 | 1.6±0.4 | 1.6(1.1,2.2) | 5.4±1.0 | 7.6(3.9,15.1) | 88.8±16.3 | |
CIMT增厚组 | 20(44.4) | 4(8.9) | 21(46.7) | 7.4±0.8 | 22.8±3.3 | 3.0±0.8 | 1.6±0.5 | 1.6(1.0,2.1) | 5.8±1.0 | 13.8(9.0,39.3) | 85.4±12.9 | |
检验统计量值 | 2.358a | 7.152 | 1.635 | 0.196 | 0.403 | 0.402b | 3.095 | 5.157b | 1.376 | |||
P值 | 0.307 | <0.001 | 0.102 | 0.844 | 0.686 | 0.687 | 0.002 | <0.001 | 0.169 | |||
组别 | LPA〔M(P25,P75),mg/L〕 | ICAM-1〔M(P25,P75),μg/L〕 | VCAM-1〔M(P25,P75),μg/L〕 | ApoA/ApoB | CRP〔M(P25,P75),mg/L〕 | ALB〔M(P25,P75),mg/L〕 | GLU(mmol/L) | 糖尿病〔n(%)〕 | ALT〔M(P25,P75),U/L〕 | AST〔M(P25,P75),U/L〕 | PHYMET〔M(P25,P75),MET-min/w〕 | |
CIMT正常组 | 135.0(64.8,282.7) | 78.1(52.8,127.0) | 225.2(170.2,299.7) | 1.7±0.6 | 0.9(0.4,1.9) | 9.1(4.7,19.3) | 5.8±1.5 | 61(8.8) | 11.8(8.9,17.0) | 24.0(20.9,29.0) | 5 593(3 564,8 319) | |
CIMT增厚组 | 229.0(117.0,284.0) | 78.1(50.4,150.5) | 298.0(216.0,352.3) | 1.5±0.7 | 1.5(0.9,2.6) | 16.1(10.5,46.0) | 6.1±1.7 | 6(13.3) | 12.0(9.8,18.0) | 26.0(22.9,33.1) | 7 479(3 885,13 146) | |
检验统计量值 | 2.461b | 0.200b | 3.341b | 1.704 | 3.213b | 4.014b | 1.183 | 1.051a | 0.807b | 1.676b | 2.451b | |
P值 | 0.013 | 0.841 | <0.001 | 0.044 | <0.001 | <0.001 | 0.237 | 0.305 | 0.420 | 0.094 | 0.014 |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
SBPa | 0.031 | 0.009 | 11.864 | 0.001 | 1.032(1.013,1.050) |
TCb | 0.444 | 0.202 | 4.831 | 0.028 | 1.558(1.049,2.315) |
PHYMET | 0.800 | 0.279 | 8.222 | 0.004 | 2.226(1.289,3.844) |
CRP | 0.380 | 0.172 | 4.881 | 0.027 | 1.462(1.043,2.050) |
超重肥胖 | -0.731 | 0.404 | 3.274 | 0.070 | 0.481(0.218,1.063) |
ACR | 0.279 | 0.147 | 3.602 | 0.057 | 1.321(0.991,1.761) |
LPA | 0.345 | 0.207 | 2.778 | 0.095 | 1.412(0.941,2.118) |
VCAM-1 | 0.743 | 0.481 | 2.386 | 0.122 | 2.102(0.819,5.393) |
肾功能 | -0.685 | 0.416 | 2.711 | 0.100 | 0.504(0.223,1.139) |
ApoA/ApoB | -0.634 | 0.351 | 3.263 | 0.071 | 0.531(0.267,1.055) |
Table 2 Multivariate Logistic regression analysis of influencing factors of the thickening of carotid intima-media thickness
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
SBPa | 0.031 | 0.009 | 11.864 | 0.001 | 1.032(1.013,1.050) |
TCb | 0.444 | 0.202 | 4.831 | 0.028 | 1.558(1.049,2.315) |
PHYMET | 0.800 | 0.279 | 8.222 | 0.004 | 2.226(1.289,3.844) |
CRP | 0.380 | 0.172 | 4.881 | 0.027 | 1.462(1.043,2.050) |
超重肥胖 | -0.731 | 0.404 | 3.274 | 0.070 | 0.481(0.218,1.063) |
ACR | 0.279 | 0.147 | 3.602 | 0.057 | 1.321(0.991,1.761) |
LPA | 0.345 | 0.207 | 2.778 | 0.095 | 1.412(0.941,2.118) |
VCAM-1 | 0.743 | 0.481 | 2.386 | 0.122 | 2.102(0.819,5.393) |
肾功能 | -0.685 | 0.416 | 2.711 | 0.100 | 0.504(0.223,1.139) |
ApoA/ApoB | -0.634 | 0.351 | 3.263 | 0.071 | 0.531(0.267,1.055) |
变量 | β(95%CI) | SE值 | t值 | P值 |
---|---|---|---|---|
SBPa | 0.017(0.009,0.025) | 0.004 | 4.166 | <0.001 |
TCb | 0.020(0.003,0.038) | 0.009 | 2.308 | 0.021 |
PHYMET | 0.022(0.002,0.041) | 0.010 | 2.119 | 0.034 |
吸烟情况 | ||||
曾经吸烟 | 0.047(-0.022,0.117) | 0.036 | 1.136 | 0.182 |
当前吸烟 | 0.076(0.011,0.141) | 0.033 | 2.305 | 0.021 |
CRP | 0.010(-0.003,0.023) | 0.007 | 1.462 | 0.144 |
ACR | 0.013(-0.001,0.023) | 0.007 | 1.771 | 0.077 |
LPA | 0.007(-0.007,0.021) | 0.007 | 1.015 | 0.311 |
ApoA/ApoB | -0.017(-0.043,0.008) | 0.013 | 1.337 | 0.182 |
饮酒情况 | ||||
曾经饮酒 | 0.028(-0.018,0.074) | 0.023 | 1.199 | 0.231 |
当前饮酒 | 0.020(-0.017,0.057) | 0.019 | 1.072 | 0.284 |
GLU | 0.057(-0.025,0.139) | 0.042 | 1.357 | 0.175 |
糖尿病一级家族史 | 0.042(-0.018,0.102) | 0.031 | 1.380 | 0.168 |
Table 3 Multiple linear regression analysis of the factors influencing carotid intima-media thickness
变量 | β(95%CI) | SE值 | t值 | P值 |
---|---|---|---|---|
SBPa | 0.017(0.009,0.025) | 0.004 | 4.166 | <0.001 |
TCb | 0.020(0.003,0.038) | 0.009 | 2.308 | 0.021 |
PHYMET | 0.022(0.002,0.041) | 0.010 | 2.119 | 0.034 |
吸烟情况 | ||||
曾经吸烟 | 0.047(-0.022,0.117) | 0.036 | 1.136 | 0.182 |
当前吸烟 | 0.076(0.011,0.141) | 0.033 | 2.305 | 0.021 |
CRP | 0.010(-0.003,0.023) | 0.007 | 1.462 | 0.144 |
ACR | 0.013(-0.001,0.023) | 0.007 | 1.771 | 0.077 |
LPA | 0.007(-0.007,0.021) | 0.007 | 1.015 | 0.311 |
ApoA/ApoB | -0.017(-0.043,0.008) | 0.013 | 1.337 | 0.182 |
饮酒情况 | ||||
曾经饮酒 | 0.028(-0.018,0.074) | 0.023 | 1.199 | 0.231 |
当前饮酒 | 0.020(-0.017,0.057) | 0.019 | 1.072 | 0.284 |
GLU | 0.057(-0.025,0.139) | 0.042 | 1.357 | 0.175 |
糖尿病一级家族史 | 0.042(-0.018,0.102) | 0.031 | 1.380 | 0.168 |
[1] |
胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220. DOI:10.3969/j.issn.1000-3614.2019.03.001.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
樊萌语,吕筠,何平平.国际体力活动问卷中体力活动水平的计算方法[J].中华流行病学杂志,2014,35(8):961-964. DOI:10.3760/cma.j.issn.0254-6450.2014.08.019.
|
[8] |
国家卫生健康委员会脑卒中防治专家委员会血管超声专业委员会,中国超声医学工程学会浅表器官及外周血管超声专业委员会,中国超声医学工程学会颅脑及颈部血管超声专业委员会.头颈部血管超声若干问题的专家共识(颈动脉部分)[J].中国脑血管病杂志,2020,17(6):346-353. DOI:10.3969/j.issn.1672-5921.2020.06.013.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
金文胜,潘长玉.国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华内分泌代谢杂志,2005,21(4):412-413. DOI:10.3760/j.issn:1000-6699.2005.04.054.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
翁根龙,徐怡芬,陆建林.社区老年颈动脉粥样硬化患者的综合干预效果评价[J].现代预防医学,2018,45(10):1787-1792.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[1] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[2] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[3] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[4] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[5] | GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng. Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis [J]. Chinese General Practice, 2025, 28(21): 2697-2704. |
[6] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[7] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[8] | WANG Xiaoyu, FENG Zhenzhen, WANG Jun, GUO Xiaochuan, LI Jiansheng. Risk Factors for Acute Kidney Injury in Acute Respiratory Distress Syndrome: a Systematic Review [J]. Chinese General Practice, 2025, 28(12): 1527-1537. |
[9] | LIAO Xingyu, TIAN Siyu, CHEN Min. The Disease Burden, Risk Factors and Predictive Analysis of Early-onset Colorectal Cancer of Different Genders between China and the World from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(08): 1004-1011. |
[10] | GU Keyi, PAN Yaojia, HAN Zheng, FU Xiaoya, GU Handong, YANG Fei, WANG Weiqiang. Correlation between Different Obesity Metabolic Phenotypes and Atherosclerosis in a Young Population: Uric Acid as Its Potential Factor [J]. Chinese General Practice, 2025, 28(07): 831-837. |
[11] | SUN Zhenzhen, CUI Qian, LOU Qingqing, CHEN Xiaodong, FANG Dan, YAO Ping, YUAN Xiaodan. Effect of Physical Activities on the Carotid Intima-media Thickening in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(06): 697-704. |
[12] | ZOU Songyan, ZHANG Riyi, LI Xiaodong, MU Yinyu. Analysis of Clinical Characteristics and Risk Factors of Systemic Sclerosis Combined with Sjögren's Syndrome [J]. Chinese General Practice, 2025, 28(06): 737-741. |
[13] | CHEN Ling, XU Rui, CHENG Xinchun, ZHANG Zhanying, XU Hong. Mechanism of Liraglutide in Oxidized Low-density Lipoprotein Induced Endothelial Cell Injury Based on NOD-like Receptor 3 Inflammasome Pathway [J]. Chinese General Practice, 2025, 28(05): 601-606. |
[14] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, DOU Guoze, MA Qing. A Predictive Nomogram for the Risk of Frailty/Pre-frailty on Inflammatory Biomarkers in the Elderly [J]. Chinese General Practice, 2025, 28(05): 587-593. |
[15] | KONG Linghong, XIE Xiaoxin, FU Yanhua, GAN Lin, YANG Xiaoyan, MA Shujing, LONG Hai. Pre-treatment and Acquired Antiretroviral Drug Resistance among People Living with HIV in Southwest China [J]. Chinese General Practice, 2025, 28(02): 242-249. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||